Pyxis Oncology (PYXS) Prepaid Assets (2020 - 2025)
Pyxis Oncology's (PYXS) quarterly Prepaid Assets came in at $3.8 million in Q4 2025, down 6.47% year-on-year from $4.0 million in Q4 2024, and down 29.35% on a QoQ basis from $5.3 million in Q3 2025.
Pyxis Oncology (PYXS) Prepaid Assets (2020 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 6 years of Prepaid Assets data on file, last reported at $3.8 million in Q4 2025.
- On a quarterly basis, Prepaid Assets fell 6.47% year-over-year to $3.8 million in Q4 2025; TTM through Dec 2025 was $3.8 million, a 6.47% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 6.47% from the prior year.
- Prepaid Assets for Q4 2025 stood at $3.8 million, down from $5.3 million in the prior quarter.
- Over the last five years, Prepaid Assets for PYXS reached as high as $6.5 million in Q2 2025 and fell as low as $859000.0 in Q3 2021.
- Historically, Prepaid Assets has averaged $4.0 million across 5 years, with a median of $3.9 million in 2024.
- Across the five-year window, Prepaid Assets soared 10621.74% in 2021 and tumbled 44.62% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $2.5 million in 2021, then jumped by 137.1% to $5.8 million in 2022, then sank by 34.43% to $3.8 million in 2023, then advanced by 5.29% to $4.0 million in 2024, then declined by 6.47% to $3.8 million in 2025.
- Per Business Quant data, the three most recent Prepaid Assets figures were $3.8 million in Q4 2025, $5.3 million in Q3 2025, and $6.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pyxis Oncology | 166.54 Mn | 99.69 Mn | 8.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | 6.54 Mn |
| Mar 31, 2025 | 4.97 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 5.17 Mn |
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 859,000.00 |
| Dec 31, 2020 | 23,000.00 |